Abner Herrman & Brock Lowered Merck & Co (MRK) Stake By $1.43 Million; Capella Education Company (CPLA) Had 4 Bulls

Merck & Co., Inc. (NYSE:MRK) Logo

Abner Herrman & Brock Llc decreased Merck & Co Inc (MRK) stake by 9.95% reported in 2017Q4 SEC filing. Abner Herrman & Brock Llc sold 25,558 shares as Merck & Co Inc (MRK)’s stock declined 4.63%. The Abner Herrman & Brock Llc holds 231,239 shares with $13.01M value, down from 256,797 last quarter. Merck & Co Inc now has $159.97 billion valuation. The stock decreased 0.37% or $0.22 during the last trading session, reaching $59.41. About 13.50 million shares traded or 4.89% up from the average. Merck & Co., Inc. (NYSE:MRK) has declined 14.94% since April 27, 2017 and is downtrending. It has underperformed by 26.49% the S&P500.

Among 9 analysts covering Capella Education (NASDAQ:CPLA), 4 have Buy rating, 0 Sell and 5 Hold. Therefore 44% are positive. Capella Education had 20 analyst reports since July 30, 2015 according to SRatingsIntel. The stock of Capella Education Company (NASDAQ:CPLA) earned “Equal-Weight” rating by First Analysis on Friday, November 18. BMO Capital Markets maintained Capella Education Company (NASDAQ:CPLA) rating on Friday, September 15. BMO Capital Markets has “Buy” rating and $86.0 target. The stock of Capella Education Company (NASDAQ:CPLA) earned “Outperform” rating by BMO Capital Markets on Wednesday, July 26. The stock of Capella Education Company (NASDAQ:CPLA) earned “Hold” rating by Piper Jaffray on Monday, October 16. The rating was downgraded by Credit Suisse to “Neutral” on Friday, November 18. Piper Jaffray maintained Capella Education Company (NASDAQ:CPLA) on Tuesday, July 25 with “Hold” rating. First Analysis upgraded the stock to “Buy” rating in Sunday, March 4 report. The rating was downgraded by Barrington Research on Tuesday, October 31 to “Market Perform”. Barrington Research maintained the stock with “Outperform” rating in Wednesday, October 26 report. The stock of Capella Education Company (NASDAQ:CPLA) earned “Outperform” rating by Credit Suisse on Wednesday, February 3. See Capella Education Company (NASDAQ:CPLA) latest ratings:

10/04/2018 Broker: BMO Capital Markets Rating: Buy New Target: $94.0000 Maintain
05/03/2018 Broker: BMO Capital Markets Old Rating: Outperform New Rating: Outperform Old Target: $98 New Target: $83 Maintain
05/03/2018 Broker: PiperJaffray Old Rating: Neutral New Rating: Overweight Upgrade
04/03/2018 Broker: First Analysis Rating: Buy New Target: $98.0 Upgrade
02/03/2018 Broker: BMO Capital Markets Rating: Buy New Target: $83.0 Maintain
27/11/2017 Broker: BMO Capital Markets Rating: Buy New Target: $98.0 Maintain
31/10/2017 Broker: BMO Capital Markets Rating: Outperform Old Target: $78 New Target: $103 Maintain
31/10/2017 Broker: Barrington Research Old Rating: Outperform New Rating: Market Perform Downgrade

Capella Education Company, through its subsidiaries, provides online postsecondary education and job-ready skills development services in the United States. The company has market cap of $1.08 billion. The Company’s Post-Secondary segment offers various doctoral, masterÂ’s, and bachelorÂ’s online programs for working adults in business and technology, education, nursing and health sciences, public service leadership, social and behavioral sciences, and undergraduate studies markets; and learning courses that are eligible for transfer into credit at approximately 2,000 colleges and universities. It has a 47.03 P/E ratio. At December 31, 2016, it offered approximately 1,940 online courses and 53 academic programs with 153 specializations to approximately 38,000 learners.

Investors sentiment decreased to 0.82 in Q4 2017. Its down 0.12, from 0.94 in 2017Q3. It dived, as 33 investors sold Capella Education Company shares while 49 reduced holdings. 29 funds opened positions while 38 raised stakes. 10.26 million shares or 1.03% less from 10.37 million shares in 2017Q3 were reported. Lsv Asset Management reported 15,143 shares. Mason Street Advsrs Ltd Com invested in 0.01% or 3,036 shares. Teachers Retirement Sys Of The State Of Kentucky reported 4,400 shares stake. Moreover, Voya Inv Management Lc has 0% invested in Capella Education Company (NASDAQ:CPLA). Geode Cap Limited Liability reported 109,380 shares. Qs Invsts Lc holds 0% or 2,334 shares in its portfolio. Los Angeles Cap And Equity Rech Inc has 0% invested in Capella Education Company (NASDAQ:CPLA). Bessemer Group Incorporated accumulated 0% or 11,200 shares. Stone Ridge Asset Mngmt Ltd Liability Com has 0.01% invested in Capella Education Company (NASDAQ:CPLA). Barclays Public Limited Com has invested 0% in Capella Education Company (NASDAQ:CPLA). Dupont Capital Management Corporation reported 21,900 shares. Deutsche Bancorporation Ag owns 283,382 shares. Parametric Assocs Ltd Llc accumulated 49,882 shares. Gemmer Asset Mgmt Ltd Co holds 0% or 91 shares in its portfolio. Arizona State Retirement Sys holds 0.01% of its portfolio in Capella Education Company (NASDAQ:CPLA) for 19,617 shares.

The stock increased 0.05% or $0.05 during the last trading session, reaching $92.55. About 22,858 shares traded. Capella Education Company (NASDAQ:CPLA) has risen 3.98% since April 27, 2017 and is uptrending. It has underperformed by 7.57% the S&P500.

Investors sentiment decreased to 0.94 in Q4 2017. Its down 0.12, from 1.06 in 2017Q3. It dived, as 94 investors sold MRK shares while 631 reduced holdings. 123 funds opened positions while 558 raised stakes. 1.93 billion shares or 1.34% less from 1.96 billion shares in 2017Q3 were reported. Palisades Hudson Asset Management Lp owns 3,822 shares. Mason Street Advsr Ltd Liability reported 380,986 shares. The North Carolina-based Novare Capital Mgmt has invested 0.06% in Merck & Co., Inc. (NYSE:MRK). Kayne Anderson Rudnick Mngmt Limited Co holds 0.04% or 82,084 shares. Tower Rech Ltd Llc (Trc) holds 0.39% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 54,335 shares. Orbimed Advisors Ltd Liability has 2.58% invested in Merck & Co., Inc. (NYSE:MRK). Bancorp Of Montreal Can has 0.21% invested in Merck & Co., Inc. (NYSE:MRK) for 4.21 million shares. Lenox Wealth Advisors holds 0.01% or 724 shares. Inv House Lc reported 0.43% stake. Putnam Fl Invest Mgmt reported 31,795 shares. Tower Bridge Advsr, Pennsylvania-based fund reported 105,049 shares. Rhumbline Advisers holds 4.50 million shares. Seabridge Invest Advsrs Ltd Liability Corporation invested in 0.02% or 1,383 shares. Cutler Investment Counsel Lc has invested 1.35% in Merck & Co., Inc. (NYSE:MRK). Kidder Stephen W reported 0.25% in Merck & Co., Inc. (NYSE:MRK).

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 21 have Buy rating, 0 Sell and 3 Hold. Therefore 88% are positive. Merck & Co. Inc. had 90 analyst reports since August 13, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, January 16 by SunTrust. The rating was maintained by UBS on Monday, October 30 with “Buy”. Credit Suisse maintained the stock with “Outperform” rating in Monday, February 5 report. SunTrust downgraded Merck & Co., Inc. (NYSE:MRK) on Monday, October 30 to “Hold” rating. The rating was maintained by Bank of America with “Buy” on Tuesday, November 28. The rating was initiated by Bryan Garnier & Cie with “Buy” on Friday, January 13. The firm earned “Buy” rating on Monday, April 23 by Goldman Sachs. The rating was maintained by Credit Suisse on Friday, September 8 with “Outperform”. The firm has “Buy” rating given on Monday, October 30 by Citigroup. The firm has “Hold” rating by Jefferies given on Tuesday, March 15.

Analysts await Merck & Co., Inc. (NYSE:MRK) to report earnings on May, 1 before the open. They expect $0.99 EPS, up 12.50% or $0.11 from last year’s $0.88 per share. MRK’s profit will be $2.67 billion for 15.00 P/E if the $0.99 EPS becomes a reality. After $0.98 actual EPS reported by Merck & Co., Inc. for the previous quarter, Wall Street now forecasts 1.02% EPS growth.

Abner Herrman & Brock Llc increased Travelers Cos Inc/The (NYSE:TRV) stake by 3,853 shares to 62,879 valued at $8.53M in 2017Q4. It also upped Activision Blizzard Inc (NASDAQ:ATVI) stake by 10,526 shares and now owns 97,168 shares. Johnson & Johnson (NYSE:JNJ) was raised too.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart